A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline From Stage I Invasive Ovarian Cancer

Clinical trial NCT06709872 · RECRUITING

Trial details

NCT number: NCT06709872
Sponsor: KU Leuven
Status: RECRUITING
Study type: OBSERVATIONAL

Stage I Ovarian Cancer Borderline Ovarian Tumors

Start date: 2025-06-03
Primary completion: 2029-09-03
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.